Single-use Bioreactors Market - Industry Share Analysis, Key Players and Future Prospect

The Research Report on "Single-use Bioreactors Market by Product (System, 2D, 3D Media Bag, Filtration Assemblies), Molecule (mAbs, Vaccine), Cell type (Mammalian, Bacteria), Application (R&D, Process Development), End User (Biopharma, CROs & CMOs) (2022 - 2026)", is projected to reach USD 8.8 billion by 2026 from USD 3.4 billion in 2021, at a CAGR of 21.1% during the forecast period.

Increasing biopharmaceutical R&D;

The demand for biopharmaceuticals is increasing globally due to the growing geriatric population, as this population group is more susceptible to a wide range of diseases. In anticipation of this demand, global companies are focusing on biopharmaceutical R&D and manufacturing for product development and increased production. The biopharmaceutical industry invests an average of six times more in R&D as a percentage of sales compared to other manufacturing industries. In 2018, the biopharmaceutical company invested USD 102 Billion (estimated) in research and development (Source: PhRMA).

Single-use technologies are an integral part of biopharmaceutical manufacturing workflows. They make up a large percentage of small- and mid-scale biopharmaceutical manufacturing, particularly in clinical testing and research and development. Due to the advantages of single-use systems over conventional biomanufacturing techniques, their adoption has increased in biopharmaceutical R&D. Thus, the rising R&D expenditure is considered a positive indicator of the growth of the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=49113750&utm_source=openpr&utm_medium=referral

Industry Segmentation In Detailed:

By product, the single-use bioreactor systems segment accounted for the largest share of the single-use bioreactors market in 2020.

Based on product, the single-use bioreactor market is categorized into single-use bioreactor systems, single-use media bags, single-use filtration assemblies, and other products such as single-use vessels, tubing, connectors, control systems, and probes/sensors, among others. The single-use bioreactor systems segment dominated the market in 2020. SUB systems offer benefits such as lower capital investment, lower operating expenses, and lower environmental footprint, thus driving the growing adoption of these systems in biopharma applications.

By type, the stirred-tank SUBs segment accounted for the largest share of the single-use bioreactors market in 2020.

Based on type, the single-use bioreactor market is categorized into wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors such as hybrid bioreactors and SUBs with vertically perforated discs. The stirred-tank SUBs segment dominated the market in 2020. The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures. Stirred-tank SUBs promote greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=49113750&utm_source=openpr&utm_medium=referral

Leading Key Players and Analysis:

Sartorius Stedim Biotech (France), Thermo Fisher Scientific (US), Danaher Corporation (US), and Merck KGaA (Germany) are the prominent players operating in the single-use bioreactors market.

Geographical Analysis in Detailed:

In 2020, North America accounted for the largest share of the single-use bioreactors market, followed by Europe. The large share of the North American regional segment can be attributed to the presence of established biopharmaceutical industry and the presence of major players operating in the market in North America.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=49113750&utm_source=openpr&utm_medium=referral

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.